Physician

Phong Tien Nguyen, D.O.

According to 2025 Medicare claims, Phong Nguyen, D.O. (NPI: 1831389063) practices anesthesiology in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is INTEGRATED PAIN ASSOCIATES PLLC (NPI: 1689800419; TIN: 900491630) and primary practice location at 79761-4655.

Nguyen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 124 traditional Medicare patients, billed 1,879 HCPCS/CPT codes, and received $123,266 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 1,997 prescription claims across 328 beneficiaries totaling $48,707 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 31 records totaling $2,836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $14,898 and ending at $123,266. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,516 and ending at $48,707. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	162	199	$14,898
2016	262	292	$20,805
2017	55	55	$4,042
2018	18	37	$1,874
2019	17	34	$1,744
2020	19	50	$2,345
2021	17	31	$1,698
2022	15	32	$912
2023	11	33	$1,336
2024	124	1,879	$123,266

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	55	184	$9,516
2016	46	142	$12,826
2017	35	55	$3,882
2018	31	70	$10,255
2019	56	96	$13,139
2020	38	72	$5,188
2021	36	67	$4,126
2022	32	72	$4,847
2023	34	52	$3,457
2024	328	1,997	$48,707

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	50	53	$242
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	42	68	$193
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	54	54	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	97	374	$98
80305	Testing for presence of drug, read by direct observation	91	138	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	599	17,084	$17,888
Pregabalin	Pregabalin	201	5,940	$4,127
Acetaminophen-Codeine	Acetaminophen With Codeine	164	4,491	$3,516
Gabapentin	Gabapentin	209	6,442	$2,538
Tizanidine Hcl	Tizanidine Hcl	156	4,684	$1,401

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$2,836	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Phong Tien Nguyen, D.O.?

Tedicare shows public-source Medicare data for Phong Tien Nguyen, D.O. (NPI 1831389063), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Phong Tien Nguyen, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Phong Tien Nguyen, D.O.?

Phong Tien Nguyen, D.O. is linked to INTEGRATED PAIN ASSOCIATES PLLC (billing NPI 1689800419) in the available physician profile data.

Does Phong Tien Nguyen, D.O. have Open Payments data?

Phong Tien Nguyen, D.O. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.